Learn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.

A team of biologists at Queen Mary University of London has discovered that a neurohormone controlling appetite in humans has ...

Famed for her approach, Dr Jo Mennie, practitioner at Get Harley and co-founder of Løuco, is the go-to skin expert for ...

One of the most buzz-worthy skincare ingredients at the moment is all about plumping and replenishing the skin: peptides.

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

A group of researchers from Arizona State University and University of Arizona have published their work on a new treatment ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...

Mount Sinai scientists will continue studying PGV001 in larger groups of patients and testing how it works with other cancer treatments. Data from this phase 1 study have prompted three additional ...

This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid ...

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...